IBDEI10S ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16585,1,4,0)
;;=4^C90.01
;;^UTILITY(U,$J,358.3,16585,2)
;;=^267515
;;^UTILITY(U,$J,358.3,16586,0)
;;=C90.00^^61^775^178
;;^UTILITY(U,$J,358.3,16586,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16586,1,3,0)
;;=3^Multiple Myeloma,Not in Remission
;;^UTILITY(U,$J,358.3,16586,1,4,0)
;;=4^C90.00
;;^UTILITY(U,$J,358.3,16586,2)
;;=^5001752
;;^UTILITY(U,$J,358.3,16587,0)
;;=C94.6^^61^775^179
;;^UTILITY(U,$J,358.3,16587,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16587,1,3,0)
;;=3^Myelodysplastic Disease NEC
;;^UTILITY(U,$J,358.3,16587,1,4,0)
;;=4^C94.6
;;^UTILITY(U,$J,358.3,16587,2)
;;=^5001846
;;^UTILITY(U,$J,358.3,16588,0)
;;=D61.82^^61^775^180
;;^UTILITY(U,$J,358.3,16588,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16588,1,3,0)
;;=3^Myelophthisis
;;^UTILITY(U,$J,358.3,16588,1,4,0)
;;=4^D61.82
;;^UTILITY(U,$J,358.3,16588,2)
;;=^334037
;;^UTILITY(U,$J,358.3,16589,0)
;;=D47.9^^61^775^181
;;^UTILITY(U,$J,358.3,16589,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16589,1,3,0)
;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
;;^UTILITY(U,$J,358.3,16589,1,4,0)
;;=4^D47.9
;;^UTILITY(U,$J,358.3,16589,2)
;;=^5002260
;;^UTILITY(U,$J,358.3,16590,0)
;;=D53.9^^61^775^185
;;^UTILITY(U,$J,358.3,16590,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16590,1,3,0)
;;=3^Nutritional Anemia,Unspec
;;^UTILITY(U,$J,358.3,16590,1,4,0)
;;=4^D53.9
;;^UTILITY(U,$J,358.3,16590,2)
;;=^5002298
;;^UTILITY(U,$J,358.3,16591,0)
;;=D47.4^^61^775^186
;;^UTILITY(U,$J,358.3,16591,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16591,1,3,0)
;;=3^Osteomyelofibrosis
;;^UTILITY(U,$J,358.3,16591,1,4,0)
;;=4^D47.4
;;^UTILITY(U,$J,358.3,16591,2)
;;=^5002259
;;^UTILITY(U,$J,358.3,16592,0)
;;=D51.3^^61^775^210
;;^UTILITY(U,$J,358.3,16592,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16592,1,3,0)
;;=3^Vitamin B12 Deficiency Anemia,Other
;;^UTILITY(U,$J,358.3,16592,1,4,0)
;;=4^D51.3
;;^UTILITY(U,$J,358.3,16592,2)
;;=^5002287
;;^UTILITY(U,$J,358.3,16593,0)
;;=D77.^^61^775^62
;;^UTILITY(U,$J,358.3,16593,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16593,1,3,0)
;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
;;^UTILITY(U,$J,358.3,16593,1,4,0)
;;=4^D77.
;;^UTILITY(U,$J,358.3,16593,2)
;;=^5002396
;;^UTILITY(U,$J,358.3,16594,0)
;;=D58.2^^61^775^88
;;^UTILITY(U,$J,358.3,16594,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16594,1,3,0)
;;=3^Hemoglobinopathies,Other
;;^UTILITY(U,$J,358.3,16594,1,4,0)
;;=4^D58.2
;;^UTILITY(U,$J,358.3,16594,2)
;;=^87629
;;^UTILITY(U,$J,358.3,16595,0)
;;=C88.8^^61^775^110
;;^UTILITY(U,$J,358.3,16595,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16595,1,3,0)
;;=3^Malig Immunoproliferative Diseases,Other
;;^UTILITY(U,$J,358.3,16595,1,4,0)
;;=4^C88.8
;;^UTILITY(U,$J,358.3,16595,2)
;;=^5001750
;;^UTILITY(U,$J,358.3,16596,0)
;;=D70.8^^61^775^183
;;^UTILITY(U,$J,358.3,16596,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16596,1,3,0)
;;=3^Neutropenia,Other
;;^UTILITY(U,$J,358.3,16596,1,4,0)
;;=4^D70.8
;;^UTILITY(U,$J,358.3,16596,2)
;;=^334042
;;^UTILITY(U,$J,358.3,16597,0)
;;=D59.4^^61^775^184
;;^UTILITY(U,$J,358.3,16597,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16597,1,3,0)
;;=3^Nonautoimmune Hemolytic Anemias,Other
;;^UTILITY(U,$J,358.3,16597,1,4,0)
;;=4^D59.4
;;^UTILITY(U,$J,358.3,16597,2)
;;=^5002326
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI10S 3782 printed Nov 22, 2024@17:09:42 Page 2
IBDEI10S ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16585,1,4,0)
+2 ;;=4^C90.01
+3 ;;^UTILITY(U,$J,358.3,16585,2)
+4 ;;=^267515
+5 ;;^UTILITY(U,$J,358.3,16586,0)
+6 ;;=C90.00^^61^775^178
+7 ;;^UTILITY(U,$J,358.3,16586,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,16586,1,3,0)
+10 ;;=3^Multiple Myeloma,Not in Remission
+11 ;;^UTILITY(U,$J,358.3,16586,1,4,0)
+12 ;;=4^C90.00
+13 ;;^UTILITY(U,$J,358.3,16586,2)
+14 ;;=^5001752
+15 ;;^UTILITY(U,$J,358.3,16587,0)
+16 ;;=C94.6^^61^775^179
+17 ;;^UTILITY(U,$J,358.3,16587,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,16587,1,3,0)
+20 ;;=3^Myelodysplastic Disease NEC
+21 ;;^UTILITY(U,$J,358.3,16587,1,4,0)
+22 ;;=4^C94.6
+23 ;;^UTILITY(U,$J,358.3,16587,2)
+24 ;;=^5001846
+25 ;;^UTILITY(U,$J,358.3,16588,0)
+26 ;;=D61.82^^61^775^180
+27 ;;^UTILITY(U,$J,358.3,16588,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,16588,1,3,0)
+30 ;;=3^Myelophthisis
+31 ;;^UTILITY(U,$J,358.3,16588,1,4,0)
+32 ;;=4^D61.82
+33 ;;^UTILITY(U,$J,358.3,16588,2)
+34 ;;=^334037
+35 ;;^UTILITY(U,$J,358.3,16589,0)
+36 ;;=D47.9^^61^775^181
+37 ;;^UTILITY(U,$J,358.3,16589,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,16589,1,3,0)
+40 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
+41 ;;^UTILITY(U,$J,358.3,16589,1,4,0)
+42 ;;=4^D47.9
+43 ;;^UTILITY(U,$J,358.3,16589,2)
+44 ;;=^5002260
+45 ;;^UTILITY(U,$J,358.3,16590,0)
+46 ;;=D53.9^^61^775^185
+47 ;;^UTILITY(U,$J,358.3,16590,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,16590,1,3,0)
+50 ;;=3^Nutritional Anemia,Unspec
+51 ;;^UTILITY(U,$J,358.3,16590,1,4,0)
+52 ;;=4^D53.9
+53 ;;^UTILITY(U,$J,358.3,16590,2)
+54 ;;=^5002298
+55 ;;^UTILITY(U,$J,358.3,16591,0)
+56 ;;=D47.4^^61^775^186
+57 ;;^UTILITY(U,$J,358.3,16591,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,16591,1,3,0)
+60 ;;=3^Osteomyelofibrosis
+61 ;;^UTILITY(U,$J,358.3,16591,1,4,0)
+62 ;;=4^D47.4
+63 ;;^UTILITY(U,$J,358.3,16591,2)
+64 ;;=^5002259
+65 ;;^UTILITY(U,$J,358.3,16592,0)
+66 ;;=D51.3^^61^775^210
+67 ;;^UTILITY(U,$J,358.3,16592,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,16592,1,3,0)
+70 ;;=3^Vitamin B12 Deficiency Anemia,Other
+71 ;;^UTILITY(U,$J,358.3,16592,1,4,0)
+72 ;;=4^D51.3
+73 ;;^UTILITY(U,$J,358.3,16592,2)
+74 ;;=^5002287
+75 ;;^UTILITY(U,$J,358.3,16593,0)
+76 ;;=D77.^^61^775^62
+77 ;;^UTILITY(U,$J,358.3,16593,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,16593,1,3,0)
+80 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
+81 ;;^UTILITY(U,$J,358.3,16593,1,4,0)
+82 ;;=4^D77.
+83 ;;^UTILITY(U,$J,358.3,16593,2)
+84 ;;=^5002396
+85 ;;^UTILITY(U,$J,358.3,16594,0)
+86 ;;=D58.2^^61^775^88
+87 ;;^UTILITY(U,$J,358.3,16594,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,16594,1,3,0)
+90 ;;=3^Hemoglobinopathies,Other
+91 ;;^UTILITY(U,$J,358.3,16594,1,4,0)
+92 ;;=4^D58.2
+93 ;;^UTILITY(U,$J,358.3,16594,2)
+94 ;;=^87629
+95 ;;^UTILITY(U,$J,358.3,16595,0)
+96 ;;=C88.8^^61^775^110
+97 ;;^UTILITY(U,$J,358.3,16595,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,16595,1,3,0)
+100 ;;=3^Malig Immunoproliferative Diseases,Other
+101 ;;^UTILITY(U,$J,358.3,16595,1,4,0)
+102 ;;=4^C88.8
+103 ;;^UTILITY(U,$J,358.3,16595,2)
+104 ;;=^5001750
+105 ;;^UTILITY(U,$J,358.3,16596,0)
+106 ;;=D70.8^^61^775^183
+107 ;;^UTILITY(U,$J,358.3,16596,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,16596,1,3,0)
+110 ;;=3^Neutropenia,Other
+111 ;;^UTILITY(U,$J,358.3,16596,1,4,0)
+112 ;;=4^D70.8
+113 ;;^UTILITY(U,$J,358.3,16596,2)
+114 ;;=^334042
+115 ;;^UTILITY(U,$J,358.3,16597,0)
+116 ;;=D59.4^^61^775^184
+117 ;;^UTILITY(U,$J,358.3,16597,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,16597,1,3,0)
+120 ;;=3^Nonautoimmune Hemolytic Anemias,Other
+121 ;;^UTILITY(U,$J,358.3,16597,1,4,0)
+122 ;;=4^D59.4
+123 ;;^UTILITY(U,$J,358.3,16597,2)
+124 ;;=^5002326
